InMed shareholders re-elect all five directors, approve auditor and share issuance at AGM

InMed Pharmaceuticals Inc.

All five director nominees elected with 81.9% to 82.1% support.
Appointment of CBIZ CPAs P.C. as auditor for 2026 approved (78.8% for).
Shareholders approved potential issuance of >=20% of shares under SEPA with YA II PN (65.9% for).
Turnout was 993,491 shares (35.43% of outstanding).

item 5.07item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.